The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse.

Recombinant human erythropoietin (rHuEpo) has recently become available for the treatment of chronic anaemia, including that associated with cancer. Carcinoma NT in CBA mice causes a progressive anaemia which can be overcome by daily injections of recombinant human erythropoietin (rHuEpo). This mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Joiner, B., Hirst, V. K., McKeown, S. R., McAleer, J. J., Hirst, D. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968603/
https://www.ncbi.nlm.nih.gov/pubmed/8398699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968603/
https://www.ncbi.nlm.nih.gov/pubmed/8398699

Ejemplares similares